Literature DB >> 2838305

Indications for P2-purinoceptor subtypes in guinea pig smooth muscle.

N P Wiklund1, L E Gustafsson.   

Abstract

The effects of ADP, ATP, 2-methylthio ATP, alpha,beta-methylene ADP (alpha,beta meADP) and alpha,beta meATP on smooth muscle tone and the responses to transmural nerve stimulation were studied in isolated longitudinal ileum muscle, in vas deferens and in taenia coli of the guinea pig. The nucleotides evoked contractile responses in the ileum and vas deferens preparations which were blocked by p-chloromercuribenzene sulfonic acid (PCMBS) and evoked relaxation in the taenia which was not affected by PCMBS. The potency order of the agonists in the ileum (2-methylthio ATP was more potent than ATP which was equipotent with ADP) is consistent with the suggestion that there are P2Y receptors in the taenia. The antagonist pattern, including the inefficacy of reactive blue 2, instead suggests a similarity between the ileum receptors and the P2X receptors in vas deferens. However, alpha,beta meATP did not antagonize the contractile effect of ATP in the ileum, in contrast to its effect in the vas deferens where alpha,beta meATP did abolish the contractile effect of ATP. The possibilities for classification of a new receptor/site of purine nucleotide action, P2S, are considered.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838305     DOI: 10.1016/0014-2999(88)90114-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

1.  Cibacron blue stimulation of surfactant secretion in rat type II pneumocytes.

Authors:  M Griese; L I Gobran; S A Rooney
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

2.  Purinoceptors mediating relaxation and spasm in the rat gastric fundus.

Authors:  M S Matharu; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

3.  Evidence for two separate vasoconstriction-mediating nucleotide receptors, both distinct from the P2x-receptor, in rabbit basilar artery: a receptor for pyrimidine nucleotides and a receptor for purine nucleotides.

Authors:  I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

4.  Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens.

Authors:  I von Kügelgen; E Schöffel; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

5.  Subtypes of purinoceptors in rat and dog urinary bladder smooth muscles.

Authors:  H Suzuki; S Kokubun
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  Rise in cytosolic Ca2+ concentration induced by P2-purinoceptor activation in isolated myocytes from the rat gastrointestinal tract.

Authors:  H M Blottière; G Loirand; P Pacaud
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

7.  Post-receptor pathway of the ATP-induced relaxation in smooth muscle of the mouse vas deferens.

Authors:  P Gailly; B Boland; C Paques; B Himpens; R Casteels; J M Gillis
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

8.  Adenosine 5'-[alpha beta-methylene]triphosphate potentiates the oscillatory cytosolic Ca2+ responses of hepatocytes to ATP, but not to ADP.

Authors:  C J Dixon; P H Cobbold; A K Green
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

9.  Effect of nucleotides on the cytosolic free calcium activity and inositol phosphate formation in human glomerular epithelial cells.

Authors:  H Pavenstädt; M Späth; G Schlunck; M Nauck; R Fischer; C Wanner; P Schollmeyer
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

10.  ATP activates P2x-contracting and P2y-relaxing purinoceptors in the smooth muscle of mouse vas deferens.

Authors:  B Boland; B Himpens; M F Vincent; J M Gillis; R Casteels
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.